CIBC Private Wealth Group LLC Cuts Position in UnitedHealth Group Incorporated (NYSE:UNH)

CIBC Private Wealth Group LLC lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 3.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,438,738 shares of the healthcare conglomerate’s stock after selling 43,985 shares during the period. UnitedHealth Group comprises approximately 1.4% of CIBC Private Wealth Group LLC’s holdings, making the stock its 11th biggest holding. CIBC Private Wealth Group LLC owned about 0.16% of UnitedHealth Group worth $754,647,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in the stock. Joseph Group Capital Management boosted its position in shares of UnitedHealth Group by 15.6% in the fourth quarter. Joseph Group Capital Management now owns 7,408 shares of the healthcare conglomerate’s stock worth $3,747,000 after buying an additional 998 shares during the period. RWA Wealth Partners LLC grew its position in UnitedHealth Group by 1.0% in the fourth quarter. RWA Wealth Partners LLC now owns 60,031 shares of the healthcare conglomerate’s stock valued at $30,368,000 after acquiring an additional 565 shares in the last quarter. Barrow Hanley Mewhinney & Strauss LLC boosted its stake in shares of UnitedHealth Group by 3.1% in the fourth quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 716,647 shares of the healthcare conglomerate’s stock valued at $362,523,000 after purchasing an additional 21,402 shares during the period. American Money Management LLC increased its stake in UnitedHealth Group by 15.7% during the 4th quarter. American Money Management LLC now owns 2,408 shares of the healthcare conglomerate’s stock worth $1,218,000 after buying an additional 326 shares during the period. Finally, Allianz SE purchased a new position in UnitedHealth Group in the 4th quarter valued at about $25,802,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research analysts recently commented on UNH shares. Cantor Fitzgerald reissued an “overweight” rating and issued a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Barclays dropped their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research note on Friday, January 17th. Wells Fargo & Company decreased their price objective on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. Finally, HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective on the stock in a research note on Friday, January 10th. Twenty analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, UnitedHealth Group has an average rating of “Buy” and a consensus target price of $629.32.

Insider Activity

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the firm’s stock in a transaction that occurred on Friday, January 17th. The stock was purchased at an average price of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. 0.33% of the stock is currently owned by company insiders.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $515.47 on Friday. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The stock has a market cap of $471.51 billion, a price-to-earnings ratio of 33.26, a PEG ratio of 1.37 and a beta of 0.62. The stock’s 50 day moving average price is $508.81 and its 200 day moving average price is $544.24. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same period in the previous year, the company earned $5.83 earnings per share. UnitedHealth Group’s revenue was up 6.8% compared to the same quarter last year. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.63%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s payout ratio is 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.